Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
China
Biotech
MindRank reports 10% weight loss on oral GLP-1 drug in phase 2b
The Chinese phase 2b obesity trial suggests efficacy is in the same ballpark as Eli Lilly’s orforglipron but MindRank's drug was given twice a day.
Nick Paul Taylor
Jun 24, 2025 10:06am
Corxel, Sciwind post data as China's obesity push gathers pace
Jun 23, 2025 9:20am
FDA blocks new clinical trials that ship cells from US to China
Jun 20, 2025 10:30am
US may be ending grants for biotechs with foreign investors
Jun 18, 2025 11:50am
China's rapid rise creates 'heightened risks' for pharma: PwC
Jun 18, 2025 5:00am
US biotechs must adapt as global competition rises: Antares CEO
Jun 17, 2025 8:15am
